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ta.2012.1Abstract Introduction: Thyroglossal duct cyst is the most common congenital neck mass. This
mass is known to be benign and only few cases (1%) may develop papillary carcinoma.
Aim: To present 2 cases of papillary carcinoma originated from the thyroglossal duct cyst and
review the literature regarding the optimal therapeutic approach.
Method: Case report.
Results: Papillary carcinoma develops in a thyroglossal duct cyst in 1% of cases. In this article
we presented 2 cases of papillary carcinoma in thyroglossal duct cyst with normal thyroid gland
treated with two different approaches. One patient in 1997 was treated with a Sistrunk approach
and a total thyroidectomy, and the other in 2012 was treated with a only a Sistrunk approach.
Conclusion: Through time there were many controversies concerning the management of the
papillary carcinoma in the thyroglossal duct cyst. In our article and after a review of the literature
we concluded that in patients with normal thyroid gland and no lymphadenopathy (N0) the best
treatment was limited to the complete excision of the thyroglossal duct cyst using a Sistrunk
approach.
ª 2012 Egyptian Society of Ear, Nose, Throat and Allied Sciences.
Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Thyroglossal duct cyst is the most frequent congenital neck
mass that is due to failure of regression of the thyroglossal duct
(TGD). This anomaly can be present in 7% of the adult pop-
ulation.1 This mass is known to be benign and only few cases
(1%) may develop papillary carcinoma.171293.
l.com (C. Farah).
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0.003In this article, we present 2 cases of thyroglossal duct cyst
carcinoma with two different therapeutic approaches with a re-
view of the literature, in order to achieve the best therapeutic
strategy to this uncommon pathology.
2. Cases
2.1. Case 1
In 1997, a 27 year old woman, smoker, with no past medical
history, presented to our department, referred by her general
surgeon, for a midline cervical mass of 2 cm discovered a year
ago and that has not changed in size. Palpation revealed a 2 cm
soft mass that moved with the protrusion of the tongue and
swallowing, with no evidence of cervical lymphadenopathy
and normal thyroid gland. A cervical ultra sound showed aces. Production and hosting by Elsevier B.V. All rights reserved.
Figure 2 Cervical MRI (T2) showing an infrahyoid multilobu-
lated mass (white arrow).
134 C. Nassif et al.1.5 · 2.5 cm midline heterogenic mass containing calciﬁcations
with a normal aspect of the thyroid. A radioiodine scan
showed a homogenous enhancement of the thyroid gland with
no enhancement of the midline mass. A ﬁne needle aspiration
of the mass was in favor of a thyroglossal duct cyst.
A Sistrunk procedure was carried out and histopathologic
examination was in favor of a papillary thyroid carcinoma.
Afterwards this patient was operated of a total thyroidec-
tomy by her general surgeon in another hospital. Histopatho-
logic examination of the thyroid showed normal thyroid tissue
with no sign of malignancy.
2.2. Case 2
In 2012, a 27 year old patient with no past medical history,
presented to our department after a three week history of an
asymptomatic midline infrahyoid cervical mass. The patient
had neither dysphagia nor dyspnea. Palpation revealed a
3 cm non-tender, indurated mass that moved with the protru-
sion of the tongue and swallowing. There was no evidence of
cervical lymphadenopathy. A cervical ultra sound showed a
33 mm heterogenic cystic image containing hyperechoic mass
with a normal aspect of the thyroid gland (Fig. 1).
A cervical MRI (Fig. 2) revealed the presence of an infrahy-
oid cystic multilobulated encapsulated mass.
The diagnosis of thyroglossal duct cyst was evoked and a
Sistrunk procedure was performed. Intraoperatively, the mass
was multilobulated and well encapsulated (Fig. 3).
Histopathologic examination revealed the presence of a
papillary thyroid carcinoma (Fig. 4).
3. Discussion
During the fourth week of embryogenesis, the thyroid gland
forms at the foramen cecum of the tongue. This diverticulumFigure 1 Cervical ultra sound showing a cystic image containing
a hyperechoic mass (white arrow).
Figure 3 Intraoperative ﬁndings: a multilobulated well encap-
sulated infra-hyoid midline cervical mass (white arrow).
Figure 4 Histopathologic examination. (A) Papillary formations
(black arrows) in the cyst wall (white arrow). (B) Nuclear grooves
(black arrow).migrates downward to its adult location below the hyoid bone
and anterior to the trachea and thyroid cartilage by the seventh
week. During the descent, the thyroid gland remains connected
to the base of the tongue by means of the thyroglossal duct. If
this duct subsequently fails to atrophy it may give rise to a
Figure 5 Algorithm of the treatment of papillary carcinoma of
TGD cyst (TGD= thyroglossal duct).
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of the tongue to the thyroid gland.
Papillary carcinoma of thyroglossal duct cyst is uncommon,
but is usually encountered in the fourth decade of life with a
slight female predominance.2 Since Brentano’s ﬁrst description
in 1911,3 approximately 200 cases have been reported in the
world literature. Its true incidence is difﬁcult to deﬁne pre-
cisely, but it is approximately 1% of all TGD cysts.
The clinical presentation of a TGD cyst carcinoma is often
very similar to that of its benign counterpart. Therefore, in
most cases the diagnosis of malignancy is not made until after
surgery. Nevertheless, carcinoma should be suspected in any
cyst that is hard, ﬁxed, irregular, or is associated with
lymphadenopathy.4
Even though the diagnosis of papillary carcinoma of the
TGD may be suspected intraoperatively, only histopathologic
examination will conﬁrm it. According to Widstrom et al.,5 the
carcinoma should ﬁrst be in the wall of the TGD cyst. Second,
the TGD carcinoma must be differentiated from a cystic lymph
node metastasis by histologic demonstration of a squamous or
columnar epithelial lining and normal thyroid follicles in the
wall of the cyst. And third, there should be no malignancy in
the thyroid gland or any other possible primary site.
There is universal agreement that the Sistrunk procedure is
the minimum and arguably all that is necessary in the manage-
ment of uncomplicated, ‘‘low-risk’’ TGD carcinomas. In the
retrospective review of 62 patients conducted by Patel et al.,2
univariate analysis of prognostic factors predictive of overall
survival in patients with TGD carcinoma revealed that the
only signiﬁcant predictor of outcome was the extent of surgery
for the TGD cyst, whereas the size of the tumor had no effect
on the outcome.
Much of the controversy in the management of TGD carci-
nomas revolves around the best method of management of an
otherwise clinically normal thyroid gland.The univariate analysis of Patel et al.2 of the prognostic fac-
tors predictive of overall survival revealed that the addition of
total thyroidectomy to the Sistrunk procedure did not have
signiﬁcant impact on ‘‘outcome’’ (P= 0.1). It is therefore ar-
gued that in the low-risk group, in the presence of a clinically
or radiologically normal thyroid gland, total thyroidectomy in
addition to the Sistrunk procedure is not necessary.
The impact of neck dissection in the management of N0
TGD papillary carcinoma is still a controversy. However, if
extrapolations are made from the treatment of the N0 neck
in well-differentiated carcinoma of the thyroid gland, then
selective nodal dissection for TGD thyroid carcinoma may
be unnecessary.6
Although there are few data to support the role of thyroid
suppression after a straightforward Sistrunk procedure, thy-
roxine suppression therapy and regular measurement of thyro-
globulin has been recommended.7
The prognosis is generally excellent with adequately treated
disease.
Of the 62 patients followed for a median of 71 months
(range, 1–456 months), as reviewed by Patel et al.,2 the
5- and 10-year Kaplan–Meier overall survival rates were
100% and 95.6% respectively.
Knowing that there is no clear consensus regarding the
management of papillary carcinoma of the thyroglossal duct
cyst, and based on recent studies, we propose an algorithm
guiding the therapeutic approach of this pathology (Fig. 5).
4. Conclusion
TGD cyst carcinoma is uncommon, occurring in approxi-
mately 1% of all TGD cysts. The majority are well differenti-
ated papillary thyroid carcinomas, and are often diagnosed
incidentally after surgical excision. The Sistrunk operation is
adequate for most patients in the presence of a clinically and
radiologically normal gland. More aggressive treatment,
including total thyroidectomy with or without neck dissection,
radioactive iodine ablation therapy, and thyroid-stimulating
hormone suppression, is necessary in more advanced cases
(Concomitant papillary carcinoma of the thyroid gland or po-
sitive lymphadenopathy).
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